All Blogs

Jun 18, 2019

Bluebird declares the price of its gene therapy- Zynteglo Bluebird Bio has set the price of its gene therapy Zynteglo at USD 1.8 million. Zynteglo, so far, has only been approved for treating rare blood disorders in the Europe Union. The full price of Zynteglo can be dispersed out for five years, at approx...

Sep 30, 2024

An orphan disease is any disease that affects only a small percentage of the population. As many as 7,000 rare diseases affect human life. The total number of Americans living with a rare disease is estimated at between 25 and 30 million. In the EU, rare disease patients comprise 6% to 8 % of the population. One...

Jun 14, 2019

World Blood Donor Day 14 June is observed and celebrated as World Blood Donor Day around the world. It is for raising awareness for donating blood who are in need and express gratitude towards voluntary, and unpaid blood donors for saving others’ lives. Let us all come forward and save lives!

Sep 30, 2024

Pompe disease, an inherited rare disease, is often fatal and incapacitates the heart and skeletal muscles. The absence of an essential protein due to the mutation in a gene encoding GAA, leads to a complex buildup of sugar, hence, damaging the heart, liver, and other organs. The mutated gene hampers the lysosomal-m...

Jun 13, 2019

Telegenomics Company Genome Medical nets USD 23 M Genome Medical, a telegenomics company, having expertise in delivering genome-based medicine has raised USD 23 Million in series B funding.  The proceeds will be used by the company to accelerate the development of its technology and medical services to supp...

Jun 12, 2019

The study published in The New England Journal of Medicine set out to study the effect of the drug teplizumab in people at high risk for type 1 diabetes. According to recent Phase II clinical trials, in experimental immunotherapy conducted, the drug has been able to delay the onset of disease for the first tim...

Jun 11, 2019

Lilly tests the efficacy of Tirzepatide-a novel dual GIP, GLP-1 agonist Eli Lilly is planning to test its diabetes drug Tirzepatide in a phase 2b Non-Alcoholic Steatohepatitis (NASH) trial. Tirzepatide, also known as LY3298176, has been excellent in reducing body weight and blood sugar in patients with poorly co...

Feb 12, 2025

Alzheimer’s disease currently affects an estimated 50 million people worldwide. This number is projected to rise to 75 million by 2030 and a staggering 131.5 million by 2050, according to Alzheimer's Disease International, spanning all age groups globally. While the exact cause of Alzheimer’s disease remains elusiv...

Jun 07, 2019

In layman’s language, Cluster headache is a headache disorder that occurs in cyclical patterns. The term cluster headache itself defines the condition that these attacks occur in groups, or “clusters.” During a cluster cycle, brief, excruciatingly severe headache attacks recur between 1-8 times per day. Known as on...

Jun 08, 2019

World Brain Tumor Day World Brain Tumor Day is focussed at raising awareness about brain tumor and educating people about cancer which is not very common. Every year, June 8 is seen as World Brain Tumor Day. The day is also meant for those who are suffering from a brain tumor and help them deal with the condi...